中文English
ISSN 1001-5256
CN 22-1108/R
Issue 12
Dec.  2018
Turn off MathJax
Article Contents

Epidemiology characteristics of nonalcoholic fatty liver disease in Asia

DOI: 10.3969/j.issn.1001-5256.2018.12.006
Research funding:

 

  • Published Date: 2018-12-20
  • The prevalence rate of nonalcoholic fatty liver disease (NAFLD) is constantly increasing due to the increase in the degree of industrialization in Asian countries and the change in lifestyle and dietary structure. Asia has a large population with uneven distribution and marked regional disparities in economic and education levels and lifestyle, which results in the great difference in the epidemiology of NAFLD across different regions in Asia. An understanding of epidemiological features of NAFLD, including incidence, prevalence, and mortality rates and related risk factors can provide a basis for the research on disease progression and related prevention and control strategies.

     

  • loading
  • [1] NOUREDDIN M, VIPANI A, BRESEE C, et al. NASH leading cause of liver transplant in women:Updated analysis of indications for liver transplant and ethnic and gender variances[J]. Am J Gastroenterol, 2018.[Epub ahead of print]
    [2] CHITTURI S, FARRELL GC, HASHIMOTO E, et al. Non-alcoholic fatty liver disease in the Asia-Pacific region:Definitions and overview of proposed guidelines[J]. J Gastroenterol Hepatol, 2007, 22 (6) :778-787.
    [3] WONG VW, CHAN WK, CHITTURI S, et al. Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines2017-Part 1:Definition, risk factors and assessment[J]. J Gastroenterol Hepatol, 2018, 33 (1) :70-85.
    [4] YOUNOSSI ZM, KOENIG AB, ABDELATIF D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016, 64 (1) :73-84.
    [5] SETO WK, YUEN MF. Nonalcoholic fatty liver disease in Asia:Emerging perspectives[J]. J Gastroenterol, 2017, 52 (2) :164-174.
    [6] PERUMPAIL BJ, KHAN MA, YOO ER, et al. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease[J].World J Gastroenterol, 2017, 23 (47) :8263-8276.
    [7] FARRELL GC, WONG VW, CHITTURI S. NAFLD in Asia-as common and important as in the West[J]. Nat Rev Gastroenterol Hepatol, 2013, 10 (5) :307-318.
    [8] SINGH S, KUFTINEC GN, SARKAR S. Non-alcoholic fatty liver disease in South Asians:A review of the literature[J]. J Clin Transl Hepatol, 2017, 5 (1) :76-81.
    [9] PATI GK, SINGH SP. Nonalcoholic fatty liver disease in South Asia[J]. Euroasian J Hepatogastroenterol, 2016, 6 (2) :154-162.
    [10] KARIMI-SARI H, MOUSAVI-NAEINI SM, KHONCHE A.Comments on prevalence of non-alcoholic fatty liver disease and its related factors in Iran[J]. Int J Organ Transplant Med, 2017, 8 (1) :52-53.
    [11] GOH SC, HO ELM, GOH KL. Prevalence and risk factors of nonalcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia[J]. Hepatol Int, 2013, 7 (2) :548-554.
    [12] JIE L, BIYAO Z, HIDEKI F, et al. Prevalence of non-alcoholic fatty liver disease (NAFLD) in Asia:A systematic review and meta-analysisof 195 studies and 1, 753, 168 subjects from 13 countries[C]. The 27th Asian Pacific Association for the Study of the Liver, 2018.
    [13] FAN JG, KIM SU, WONG VW. New trends on obesity and NAFLD in Asia[J]. J Hepatol, 2017, 67 (4) :862-873.
    [14] VANWAGNER LB, ARMSTRONG MJ. Lean NAFLD:A not so benign condition?[J]. Hepatol Commun, 2018, 2 (1) :5-8.
    [15] FUNG J, LEE CK, CHAN M, et al. High prevalence of non-alcoholic fatty liver disease in the Chinese-results from the Hong Kong liver health census[J]. Liver Int, 2015, 35 (2) :542-549.
    [16] LI Z, XUE J, CHEN P, et al. Prevalence of nonalcoholic fatty liver disease in mainland of China:A meta-analysis of published studies[J]. J Gastroenterol Hepatol, 2014, 29 (1) :42-51.
    [17] ESTES C, ANSTEE QM, TERESA ARIAS-LOSTE M, et al.Modeling NAFLD disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030[J]. J Hepatol, 2018, 69 (4) :896-904.
    [18] YOUNOSSI Z, TACKE F, ARRESE M, et al. Global perspectives on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis[J]. Hepatology, 2018.[Epub ahead of print]
    [19] FAZEL Y, KOENIG AB, SAYINER M, et al. Epidemiology and natural history of non-alcoholic fatty liver disease[J]. Metabolism, 2016, 65 (8) :1017-1025.
    [20] NIRIELLA MA, PATHMESWARAN A, DE SILVA ST, et al. Incidence and risk factors for non-alcoholic fatty liver disease:A 7-year follow-up study among urban, adult Sri Lankans[J]. Liver Int, 2017, 37 (11) :1715-1722.
    [21] ZHANG T, ZHANG C, ZHANG Y, et al. Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population:A prospective cohort study[J]. Atherosclerosis, 2015, 240 (1) :144-148.
    [22] WU J, HE S, XU H, et al. Non-alcoholic fatty liver disease incidence, remission and risk factors among a general Chinese population with a 6-year follow-up[J]. Sci Rep, 2018, 8 (1) :7557.
    [23] DICKSON I. NAFLD:Increased familial risk of fibrosis in NAFLD[J].Nat Rev Gastroenterol Hepatol, 2017, 14 (8) :450.
    [24] NAKAHARA T, HYOGO H, YONEDA M, et al. Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients[J]. J Gastroenterol, 2014, 49 (11) :1477-1484.
    [25] MIYAKE T, KUMAGI T, HIROOKA M, et al. Significance of exercise in nonalcoholic fatty liver disease in men:A communitybased large cross-sectional study[J]. J Gastroenterol, 2015, 50 (2) :230-237.
    [26] TAO Y, GU H, WU J, et al. Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects[J]. Endocr Res, 2015, 40 (2) :74-78.
    [27] SHEN J, WONG GL, CHAN HL, et al. PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome[J]. Aliment Pharmacol Ther, 2014, 39 (5) :532-539.
    [28] FRACANZANI AL, PETTA S, LOMBARDI R, et al. Liver and cardiovascular damage in patients with lean nonalcoholic fatty liver disease, and association with visceral obesity[J]. Clin Gastroenterol Hepatol, 2017, 15 (10) :1604-1611, e1601.
    [29] MASARONE M, FEDERICO A, ABENAVOLI L, et al. Non alcoholic fatty liver:Epidemiology and natural history[J]. Rev Recent Clin Trials, 2014, 9 (3) :126-133.
    [30] MARCUCCILLI M, CHONCHOL M. NAFLD and chronic kidney disease[J]. Int J Mol Sci, 2016, 17 (4) :562.
    [31] SINN DH, KANG D, JANG HR, et al. Development of chronic kidney disease in patients with non-alcoholic fatty liver disease:A cohort study[J]. J Hepatol, 2017, 67 (6) :1274-1280.
    [32] LEE DY, PARK JK, HUR KY, et al. Association between nonalcoholic fatty liver disease and bone mineral density in postmenopausal women[J]. Climacteric, 2018, 21 (5) :498-501.
    [33] SHEN F, ZHENG RD, SHI JP, et al. Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease[J]. Liver Int, 2015, 35 (11) :2392-2400.
    [34] FLORES A, MARRERO JA. Emerging trends in hepatocellular carcinoma:Focus on diagnosis and therapeutics[J]. Clin Med Insights Oncol, 2014, 8:71-76.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1555) PDF downloads(468) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return